MedPath

Ceftriaxone

Ceftriaxone for Injection, USP

Approved
Approval ID

7bed9b33-29e3-4f04-9766-43a21c7ad47a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 24, 2023

Manufacturers
FDA

WG Critical Care, LLC

DUNS: 829274633

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ceftriaxone

PRODUCT DETAILS

NDC Product Code44567-702
Application NumberANDA065329
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateOctober 24, 2023
Generic NameCeftriaxone

INGREDIENTS (2)

CEFTRIAXONE SODIUMActive
Quantity: 2 g in 1 1
Code: 023Z5BR09K
Classification: ACTIM
NATURAL LATEX RUBBERInactive
Quantity: 0 1 in 1 1
Code: 2LQ0UUW8IN
Classification: CNTM

Ceftriaxone

PRODUCT DETAILS

NDC Product Code44567-701
Application NumberANDA065329
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateOctober 24, 2023
Generic NameCeftriaxone

INGREDIENTS (2)

CEFTRIAXONE SODIUMActive
Quantity: 1 g in 1 1
Code: 023Z5BR09K
Classification: ACTIM
NATURAL LATEX RUBBERInactive
Quantity: 0 1 in 1 1
Code: 2LQ0UUW8IN
Classification: CNTM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ceftriaxone - FDA Drug Approval Details